Jaguar Health Enters Material Definitive Agreement

TL;DR

Jaguar Health just signed a big deal, creating a new financial obligation.

AI Summary

On November 14, 2025, Jaguar Health, Inc. entered into a material definitive agreement, creating a direct financial obligation. The company, formerly known as Jaguar Animal Health, Inc., is incorporated in Delaware and headquartered in San Francisco, California.

Why It Matters

This filing indicates a significant new financial commitment or obligation for Jaguar Health, Inc., which could impact its financial standing and future operations.

Risk Assessment

Risk Level: medium — Entering into material definitive agreements and creating financial obligations can introduce financial risks and uncertainties for a company.

Key Players & Entities

• Jaguar Health, Inc. (company) — Registrant
• November 14, 2025 (date) — Date of Report
• Jaguar Animal Health, Inc. (company) — Former Company Name
• Delaware (jurisdiction) — State of Incorporation
• San Francisco, California (location) — Principal Executive Offices

FAQ

Key Financial Figures

• $0.0001 — ich registered Common Stock, Par Value $0.0001 Per Share JAGX The Nasdaq Capital M
• $10,810,000 — ote in the original principal amount of $10,810,000 (the "Note") (the "Note Financing"). Th
• $800,000 — e carries an original issue discount of $800,000 and the Company agreed to pay $10,000 t
• $10,000 — $800,000 and the Company agreed to pay $10,000 to Lender to cover its legal fees, acco
• $2,000,000 — Note. On the Closing Date, Lender paid $2,000,000 to the Company and $8,000,000 was depos
• $8,000,000 — nder paid $2,000,000 to the Company and $8,000,000 was deposited into an account (the "Dep
• $600,000 — der will have the right to redeem up to $600,000 plus accrued interest (such amount, the
• $8,000,000 b — ). The Collateral Requirement starts at $8,000,000 but decreases by (i) $1.00 for every $2.5
• $1.00 — arts at $8,000,000 but decreases by (i) $1.00 for every $2.50 of Unsecured Outstandin
• $2.50 — 00 but decreases by (i) $1.00 for every $2.50 of Unsecured Outstanding Obligations (a
• $4,000,000 — lateral Requirement has been reduced to $4,000,000.00, and (ii) thereafter $1.00 for every
• $2.00 — 00, and (ii) thereafter $1.00 for every $2.00 of Unsecured Outstanding Obligations so
• $500,000.00 — e the balance of the Deposit Account is $500,000.00 or less, the Collateral Requirement sha
• $100,000 — eposit in the Deposit Account more than $100,000 in excess of the Collateral Requirement

Filing Documents

• d930413d8k.htm (8-K) — 38KB
• d930413dex41.htm (EX-4.1) — 34KB
• d930413dex101.htm (EX-10.1) — 111KB
• d930413dex102.htm (EX-10.2) — 31KB
• d930413dex103.htm (EX-10.3) — 42KB
• d930413dex104.htm (EX-10.4) — 47KB
• 0001193125-25-283139.txt ( ) — 507KB
• jagx-20251114.xsd (EX-101.SCH) — 3KB
• jagx-20251114_lab.xml (EX-101.LAB) — 18KB
• jagx-20251114_pre.xml (EX-101.PRE) — 11KB
• d930413d8k_htm.xml (XML) — 4KB

Financial Statements and Exhibits

Financial Statements and Exhibits (d) Exhibits Exhibit Number Description 4.1 Secured Promissory Note dated November 12, 2025 10.1 Note Purchase Agreement dated November 12, 2025 10.2 Deposit Account Control Agreement dated November 12, 2025 10.3 Guaranty dated November 12, 2025 10.4 Pledge Agreement dated November 12, 2025 104 Cover Page Interactive Data File

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. JAGUAR HEALTH, INC. By: /s/ Lisa A. Conte Name: Lisa A. Conte Title: President and Chief Executive Officer Date: November 14, 2025